Close

Raymond James Sees Potential for Large Gains in Aerie Pharma (AERI); Analyst Starts with 'Strong Buy' Rating and Price Target of $48

Go back to Raymond James Sees Potential for Large Gains in Aerie Pharma (AERI); Analyst Starts with 'Strong Buy' Rating and Price Target of $48